Claudia Alicata

680 citations
16 papers · 534 indexed · h-index 11
Topics
Immune Cell Function and Interaction (13 papers)T-cell and B-cell Immunology (6 papers)Immunotherapy and Immune Responses (4 papers)

In The Last Decade

Claudia Alicata

16 papers receiving 529 citations

Peers

Claudia Alicata
Comparison fields: 5 of 58
  • Immunology 397
  • Molecular Biology 175
  • Epidemiology 86
  • Oncology 74
  • Cancer Research 64
Replace Yaling Dou with:
Yaling Dou United States
Hamlata Dewchand United Kingdom
Simon Yue United States
Marian van de Meent Netherlands
Natan Stein Israel
Thomas Ranson France
Timo Rückert Germany
Kerri R. Thomas United States
Susanne Oberle Switzerland
Aaron S. Rapaport United States
Claudia Alicata relative to Yaling Dou United States Yaling Dou's profile →
Citations per field
00.5×3.6×
Yaling Dou · 1×
Citations per year

Countries citing papers authored by Claudia Alicata

Since Specialization
Citations

This map shows the geographic impact of Claudia Alicata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Alicata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Alicata more than expected).

Fields of papers citing papers by Claudia Alicata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Alicata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Alicata. The network helps show where Claudia Alicata may publish in the future.

Co-authorship network of co-authors of Claudia Alicata

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Alicata. A scholar is included among the top collaborators of Claudia Alicata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Alicata. Claudia Alicata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 14
2 7
3 8
4 10
5 10
6 3
7 31
8 137
9 16
10 18
11 69
12 23
13 1
14 19
15 32
16 136

About Claudia Alicata

Claudia Alicata is a scholar working on Immunology, Hematology and Reproductive Medicine, having authored 16 papers that have together received 534 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (397 citations), Hematology (54 citations) and Cancer Research (64 citations). Claudia Alicata has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Lorenzo Moretta, Enrico Maggi, Michela Falco, Alessandro Moretta, Paola Vacca, Nicola Tumino, Franco Locatelli, Alice Bertaina, Francesco Frassoni and Letizia Muccio. Their work appears in journals such as Nucleic Acids Research, The Journal of Immunology and Genome Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026